Author:
Alkadi Mohamad M.,Al-Malki Hassan A.,Asim Muhammad,Fituri Omar M.,Hamdi Ahmed F.,Elidrisi Rihab I.,Abdul Rahiman Ramzi,Elshirbeny Mostafa F.,Othman Muftah A.,Nauman Awais,Ashour Adel,Ghonimi Tarek A.,Tohid Hiba,Jarman Mona E.,Hamad Abdullah,Elshazly Mohamed B.,Abuhelaiqa Essa
Reference40 articles.
1. World Health Organization. WHO coronavirus (COVID-19) Dashboard, < https://covid19.who.int/ >[accessed 12.31.2020].
2. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the perspectives of clinical immunologists from China;Zhang;Clin Immunol,2020
3. COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?;Sarzi-Puttini;Clin Exp Rheumatol,2020
4. Calcineurin inhibitors revisited: a new paradigm for COVID-19?;Hage;Braz J Infect Dis,2020
5. COVID-19 severity in kidney transplant recipients is similar to nontransplant patients with similar comorbidities;Chavarot;Am J Transplant,2021
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献